Cartesian Therapeutics, Inc.RNACNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-75.99M
↓ 32% below average
Average (9y)
$-57.73M
Historical baseline
Range
High:$39.84M
Low:$-235.03M
CAGR
+14.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-75.99M | +67.7% |
| 2023 | $-235.03M | -690.0% |
| 2022 | $39.84M | +872.4% |
| 2021 | $-5.16M | +92.1% |
| 2020 | $-65.59M | -26.6% |
| 2019 | $-51.80M | +17.6% |
| 2018 | $-62.87M | +0.8% |
| 2017 | $-63.37M | -85.5% |
| 2016 | $-34.16M | -47.3% |
| 2015 | $-23.18M | - |